CCM
Chiron Capital Management Portfolio holdings
AUM
$115M
This Quarter Return
+4.74%
1 Year Return
+10.94%
3 Year Return
+16.4%
5 Year Return
+25.95%
10 Year Return
–
AUM
$120M
AUM Growth
+$120M
(+1.9%)
Cap. Flow
-$3.77M
Cap. Flow
% of AUM
-3.14%
Top 10 Holdings %
Top 10 Hldgs %
60.7%
Holding
85
New
13
Increased
24
Reduced
35
Closed
6
Top Buys
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
$2.24M |
| 2 |
First Trust Multi-Manager Large Growth ETF
MMLG
|
$1.72M |
| 3 |
Sherwin-Williams
SHW
|
$1.51M |
| 4 |
AT&T
T
|
$1.41M |
| 5 |
SPLK
Splunk Inc
SPLK
|
$1.29M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$6.75M |
| 2 |
CVS Health
CVS
|
$2.5M |
| 3 |
Kraft Heinz
KHC
|
$2.25M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
$2.15M |
| 5 |
Exxon Mobil
XOM
|
$1.08M |
Sector Composition
| 1 | Healthcare | 54.07% |
| 2 | Technology | 8.03% |
| 3 | Energy | 5.25% |
| 4 | Communication Services | 3.99% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$96B
| $44.4M | 36.97% |
664,082
-100,971
| -13% | -$6.75M |
|
2
Gilead Sciences
GILD
$140B
| $8.21M | 6.84% |
119,206
-4,589
| -4% | -$316K |
|
3
Pfizer
PFE
$141B
| $5.27M | 4.39% |
134,509
-19,320
| -13% | -$757K |
|
|
4
AT&T
T
$209B
| $3.01M | 2.51% |
104,647
+49,035
| +88% | +$1.41M |
|
|
SPLK
5
DELISTED
Splunk Inc
SPLK
| $2.48M | 2.07% |
17,150
+8,900
| +108% | +$1.29M |
|
|
CTXS
6
DELISTED
Citrix Systems Inc
CTXS
| $2.24M | 1.87% |
+19,100
| New | +$2.24M |
|
7
First Trust Enhanced Short Maturity ETF
FTSM
$6.16B
| $2.05M | 1.71% |
34,159
-2,481
| -7% | -$149K |
|
8
Intel
INTC
$107B
| $1.8M | 1.5% |
32,114
-2,000
| -6% | -$112K |
|
|
9
First Trust Multi-Manager Large Growth ETF
MMLG
$79.9M
| $1.72M | 1.43% |
+64,917
| New | +$1.72M |
|
|
10
Sherwin-Williams
SHW
$91.2B
| $1.7M | 1.42% |
6,242
+5,542
| +792% | +$1.51M |
|
11
First Trust Managed Municipal ETF
FMB
$1.86B
| $1.67M | 1.39% |
29,213
+2,133
| +8% | +$122K |
|
12
Home Depot
HD
$405B
| $1.62M | 1.35% |
5,085
-400
| -7% | -$128K |
|
13
Merck
MRK
$210B
| $1.62M | 1.35% |
20,850
-750
| -3% | -$58.3K |
|
14
AB InBev
BUD
$122B
| $1.59M | 1.32% |
22,060
-12,110
| -35% | -$872K |
|
15
Amazon
AMZN
$2.44T
| $1.55M | 1.29% |
451
-15
| -3% | -$51.6K |
|
16
Apple
AAPL
$3.45T
| $1.39M | 1.16% |
10,159
+297
| +3% | +$40.7K |
|
17
Enterprise Products Partners
EPD
$69.6B
| $1.32M | 1.1% |
54,525
-761
| -1% | -$18.4K |
|
18
First Trust Exchange-Traded Fund VIII First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.34B
| $1.27M | 1.06% |
23,703
+3,843
| +19% | +$206K |
|
19
Schlumberger
SLB
$55B
| $1.26M | 1.05% |
39,230
-11,770
| -23% | -$377K |
|
20
Aflac
AFL
$57.2B
| $1.23M | 1.02% |
22,832
-355
| -2% | -$19K |
|
21
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$5.3B
| $1.22M | 1.02% |
24,034
+2,674
| +13% | +$136K |
|
22
Raymond James Financial
RJF
$33.8B
| $1.21M | 1.01% |
9,300
-200
| -2% | -$26K |
|
23
Teladoc Health
TDOC
$1.37B
| $1.19M | 0.99% |
+7,124
| New | +$1.19M |
|
24
SPDR S&P Biotech ETF
XBI
$5.07B
| $1.15M | 0.96% |
8,511
+5,692
| +202% | +$770K |
|
25
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.67B
| $1.09M | 0.9% |
22,381
+4,371
| +24% | +$212K |
|